Skip to main content
UniHealth

Doctor search

Margaret Eich Mills, NP

Nurse Practitioner · Stanford

NPI 1336454792

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
16 years
Graduated 2010

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Margaret Eich Mills’s office at (650) 723-4000 to ask if they take your plan before you enroll.

State licence records

1 licence

  • Colorado APN.991849Advanced practice nurse · since 2015 · expires 2021-09-30Specialty on the licence: Adult
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$12,489

Medicare paid this office $12,489 for 125 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)48$5,178$80
Short return visit (20+ min)53$4,186$55
Long return visit (40+ min)12$1,530$102
Short return visit (20+ min)26$748$27

Who their Medicare patients are

125 Original Medicare patients in 2024. Average age 72 · Women 100% · Also on Medicaid 26% · Health risk score 1.92. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 74% · Cancer 50% · Diabetes 23% · Coronary heart disease 21% · Depression 20% · Chronic kidney disease 15% · Heart failure 14% · Atrial fibrillation 12%.

The office billed $85,939, Medicare allowed $19,715 and paid $12,489; for 196 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024125196721.92$85,939$12,489
2023162445731.68$193,697$29,944
2022151379721.76$130,838$21,987
202172130731.89$50,020$8,749
2020105297732.12$85,158$14,495
2019141342701.86$28,204$15,649
2018125246701.86$21,095$12,515
2017581,528702.15$27,169$7,142
201666156702.16$25,390$7,847
201513625,352692.37$382,345$166,533
201426633,608692.18$563,624$243,593
201323521,765692.18$547,228$293,301

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Return visit (30+ min)52$8,622$74
Return visit (30+ min)39$5,454$72
Short return visit (20+ min)75$4,480$43
Long return visit (40+ min)26$4,182$113
Long return visit (40+ min)19$3,615$110
Short return visit (20+ min)42$2,385$43

2022: 4 services

Original Medicare services billed in 2022
Return visit (30+ min)41$6,117$68
Short return visit (20+ min)72$6,026$47
Short return visit (20+ min)61$4,261$50
Return visit (30+ min)29$3,652$75

2021: 4 services

Original Medicare services billed in 2021
Return visit (30+ min)34$3,705$79
Return visit (30+ min)14$1,818$79
Short return visit (20+ min)22$1,228$47
Short return visit (20+ min)16$1,015$53

2020: 4 services

Original Medicare services billed in 2020
Return visit (30+ min)36$4,869$62
Short return visit (20+ min)59$3,492$38
Return visit (30+ min)26$3,385$63
Short return visit (20+ min)29$1,767$38

2019: 4 services

Original Medicare services billed in 2019
Return visit (30+ min)41$4,860$53
Return visit (30+ min)34$4,596$57
Short return visit (20+ min)65$3,496$36
Short return visit (20+ min)38$2,338$37

2018: 4 services

Original Medicare services billed in 2018
Return visit (30+ min)43$5,023$59
Return visit (30+ min)30$4,263$58
Short return visit (20+ min)35$1,591$38
Short return visit (20+ min)39$1,581$37

2017: 1 service

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes38$4,079$49

2016: 2 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes55$6,194$49
Return visit (30+ min)13$944$73

2015: 6 services

Original Medicare services billed in 2015
Return visit (30+ min)47$4,004$64
New patient visit (45+ min)30$2,893$96
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes33$2,237$48
Short return visit (20+ min)25$1,346$46
Injection of drug or substance under skin or into muscle28$1,183$15
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg12$51None

2014: 18 services

Original Medicare services billed in 2014
Injection, pegfilgrastim, 6 mg13$57,422None
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes88$6,281$47
Return visit (30+ min)84$6,184$64
Injection, palonosetron hcl, 25 mcg16$4,003None
Administration of chemotherapy into vein, 1 hour or less22$3,796$81
Injection, zoledronic acid, 1 mg14$3,454None
New patient visit (45+ min)31$3,090$100
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes30$2,502$83
Injection of drug or substance under skin or into muscle40$2,181$15
Initial hospital care with moderate level of medical decision making at least 75 minutes11$1,474$134
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less20$1,096$19
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$1,042$58
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less20$1,028$43
Injection of additional new drug or substance into vein23$903$14
Short return visit (20+ min)15$718$38
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count11$125$10
Injection, dexamethasone sodium phosphate, 1 mg16$18None
Injection, diphenhydramine hcl, up to 50 mg16$18None

2013: 13 services

Original Medicare services billed in 2013
Zoldedronic acid 1mg13$9,494$148
Return visit (30+ min)98$7,944$64
New patient visit (45+ min)50$5,106$102
Administration of chemotherapy into vein, 1 hour or less17$3,874$84
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes49$3,617$45
Injection of drug or substance under skin or into muscle36$2,211$16
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less31$2,209$45
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes15$1,340$89
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$1,255$60
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less14$934$20
Short return visit (20+ min)16$824$43
Injection of additional new drug or substance into vein15$751$14
Injection, diphenhydramine hcl, up to 50 mg11$16None

Medicaid work

$932 in 2019

Medicaid paid $932 for 42 billed services this clinician did in 2019, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2019
Return visit (30+ min)27$787
Short return visit (20+ min)15$145
Medicaid work by year
201942214$932

Drugs they prescribed that Part D paid

$907,307

Pharmacies billed $907,307 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 4% of their Part D prescriptions (11 of 273) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

189 generic and 84 brand-name prescriptions · $907,307 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lynparza24$383,197$15,967
Zejula17$281,752$16,574
Rubraca13$157,269$12,098
Eliquis25$16,662$666
Gabapentin27$309$11
See all 8 drugs
Every Part D drug this clinician prescribed
Lynparza24$383,197$15,967
Zejula17$281,752$16,574
Rubraca13$157,269$12,098
Eliquis25$16,662$666
Gabapentin27$309$11
Prochlorperazine Maleate15$128$9
Ondansetron14$73$5
Amlodipine Besylate16$23$1

Year by year

Part D prescribing by year
2024273744% (11)31%$907,307
20235571087% (38)None$1,148,730
20225041109% (43)30%$1,180,490
202120273None31%$654,295
20206031077% (40)33%$1,585,180
201951011310% (52)28%$874,754
20183509510% (34)25%$528,606
201747818911% (54)15%$389,140
201644317415% (67)6%$149,315
201510336None20%$43,559
20149439NoneNone$2,609
2013149558% (12)None$15,922

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Lynparza55$772,496$14,045
Rubraca15$178,520$11,901
Eliquis62$42,406$684
Xarelto18$19,937$1,108
Dexamethasone Sodium Phosphate20$1,154$58
Gabapentin54$735$14
Ondansetron42$368$9
Prochlorperazine Maleate28$319$11
Oxycodone33$298$9
Lorazepam22$146$7
Levothyroxine11$35$3
Lisinopril11$32$3

2022: 12 drugs

Part D drugs prescribed in 2022
Lynparza49$659,026$13,450
Rubraca35$413,581$11,817
Eliquis40$22,026$551
Gabapentin42$888$21
Megestrol Acetate17$513$30
Ondansetron29$354$12
Prochlorperazine Maleate21$236$11
Pantoprazole16$147$9
Lorazepam25$114$5
Oxycodone23$106$5
Hydrocodone-Acetaminophen13$94$7
Amlodipine Besylate12$41$3

2021: 5 drugs

Part D drugs prescribed in 2021
Lynparza31$416,168$13,425
Rubraca18$195,783$10,877
Ondansetron24$713$30
Megestrol Acetate15$479$32
Gabapentin13$92$7

2020: 18 drugs

Part D drugs prescribed in 2020
Rubraca49$558,270$11,393
Lynparza39$484,619$12,426
Zejula18$265,369$14,743
Lenvima11$214,025$19,457
Enoxaparin16$18,391$1,149
Xarelto14$9,671$691
Eliquis18$8,719$484
Ondansetron51$1,327$26
Megestrol Acetate21$1,297$62
Letrozole26$539$21
Ondansetron Odt11$419$38
Prochlorperazine Maleate20$350$17
Oxycodone12$307$26
Gabapentin28$195$7
Levothyroxine12$189$16
Amlodipine Besylate37$187$5
Lorazepam25$95$4
Pantoprazole13$49$4

2019: 16 drugs

Part D drugs prescribed in 2019
Rubraca32$356,647$11,145
Lynparza28$266,479$9,517
Zejula15$168,043$11,203
Xarelto14$10,654$761
Eliquis17$8,076$475
Megestrol Acetate22$1,071$49
Ondansetron30$911$30
Hydrocodone-Acetaminophen18$441$25
Prochlorperazine Maleate19$321$17
Letrozole23$267$12
Lorazepam41$251$6
Gabapentin18$207$12
Oxycodone11$199$18
Lidocaine-Prilocaine13$194$15
Metoclopramide13$91$7
Hydrochlorothiazide11$50$5

2018: 9 drugs

Part D drugs prescribed in 2018
Lynparza25$202,197$8,088
Zejula15$182,092$12,139
Ondansetron20$385$19
Letrozole14$270$19
Oxycodone13$252$19
Hydrocodone-Acetaminophen12$150$12
Lorazepam29$129$4
Gabapentin11$107$10
Potassium Chloride12$75$6

2017: 8 drugs

Part D drugs prescribed in 2017
Votrient13$135,287$10,407
Ondansetron60$1,591$27
Prochlorperazine Maleate102$1,254$12
Hydroxyurea17$1,178$69
Oxycodone15$239$16
Anastrozole16$226$14
Prednisone18$139$8
Gabapentin20$88$4

2016: 7 drugs

Part D drugs prescribed in 2016
Ondansetron69$2,118$31
Prochlorperazine Maleate104$1,801$17
Morphine Sulfate Er12$498$42
Oxycodone23$450$20
Gabapentin14$131$9
Dexamethasone18$110$6
Prednisone15$101$7

2015: 1 drug

Part D drugs prescribed in 2015
Tamoxifen Citrate11$154$14

2014: 1 drug

Part D drugs prescribed in 2014
Prochlorperazine Maleate12$106$9

2013: 4 drugs

Part D drugs prescribed in 2013
Letrozole23$2,307$100
Omeprazole18$340$19
Anastrozole11$312$28
Prochlorperazine Maleate14$105$8

Money from drug and device companies

$126 in 2023

Industry payments by year
202333None$126
202223None$143

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Myriad Genetic LaboratoriesPrecisetumor$68
1 payment
  • Meals for Precisetumor · 2023-03-02 · $68
Merck Sharp & DohmeKeytruda$33
1 payment
  • Meals for Keytruda · 2023-10-18 · $33
GlaxoSmithKlineZejula$24
1 payment
  • Meals for Zejula · 2023-10-11 · $24
See all 3 published payments
Every published payment
Merck Sharp & DohmeMeals · 2023-10-18Keytruda$33
GlaxoSmithKlineMeals · 2023-10-11Zejula$24
Myriad Genetic LaboratoriesMeals · 2023-03-02Precisetumor$68
See earlier years (2022)

2022: $143

Payments by company in 2022
GlaxoSmithKlineZejula$121
2 payments
  • Meals for Zejula · 2022-12-12 · $90
  • Meals for Zejula · 2022-09-01 · $31
Bayer HealthCare PharmaceuticalsNubeqa$22
1 payment
  • Meals for Nubeqa · 2022-03-03 · $22

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1336454792
Licence
CA 95007936, CO APN0991849-NP, OH 11684Colorado APN.991849: Expired
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LX0001X (363LX0001X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2010-08-10
NPI last updated
2025-12-31
NPI record certified
2025-12-31

This is when the NPI record was last certified, not a medical board exam.